257 related articles for article (PubMed ID: 11343755)
21. Should the patent system for new medicines be abolished?
DiMasi JA; Grabowski HG
Clin Pharmacol Ther; 2007 Nov; 82(5):488-90. PubMed ID: 17952100
[No Abstract] [Full Text] [Related]
22. Pills, patents, and power: state creation of gray markets as a limit on patent rights.
Ghosh S
Fla J Int Law; 2002; 14(2):217-60. PubMed ID: 16526138
[No Abstract] [Full Text] [Related]
23. AIDS drugs. Brazil, Thailand override big pharma patents.
Cohen J
Science; 2007 May; 316(5826):816. PubMed ID: 17495145
[No Abstract] [Full Text] [Related]
24. Gore under fire in controversy over South Africa AIDS drug law.
Wadman M
Nature; 1999 Jun; 399(6738):717-8. PubMed ID: 10391225
[No Abstract] [Full Text] [Related]
25. South Africa vs. big pharma.
Birmingham K
Nat Med; 2001 Apr; 7(4):390. PubMed ID: 11283645
[No Abstract] [Full Text] [Related]
26. Next steps against AIDS.
Nature; 2001 Apr; 410(6832):1009. PubMed ID: 11323620
[No Abstract] [Full Text] [Related]
27. Patent necessity: intellectual property dilemmas in the biotech domain and treatment equity for developing countries.
Spectar JM
Houst J Int Law; 2002; 24(2):227-78. PubMed ID: 16189914
[No Abstract] [Full Text] [Related]
28. Amendments to the Canadian Patent Act to address drug access: is help on the way?
Penner MD; Narayanan P
Food Drug Law J; 2005; 60(3):459-70. PubMed ID: 16304751
[No Abstract] [Full Text] [Related]
29. Drug patents cause fresh spat between South Africa and industry.
Jack A
BMJ; 2014 Feb; 348():g1377. PubMed ID: 24511092
[No Abstract] [Full Text] [Related]
30. Reanalyzing reverse payment settlements: a solution to the patentee's dilemma.
Wang Z
Cornell Law Rev; 2014 Jul; 99(5):1227-58. PubMed ID: 25112001
[No Abstract] [Full Text] [Related]
31. GSK: please extend patent pool to AIDS drugs.
Douste-Blazy P; Bermudez J
Lancet; 2009 Apr; 373(9672):1339. PubMed ID: 19376450
[No Abstract] [Full Text] [Related]
32. International patent protection for HIV-related therapies: patent attorney's perspective.
Pavento LC; Greene JL; McDonald JK
Emory Int Law Rev; 2003; 17(2):919-31. PubMed ID: 15199935
[No Abstract] [Full Text] [Related]
33. Unsettling drug patent settlements: a framework for presumptive illegality.
Carrier MA
Mich Law Rev; 2009 Oct; 108(1):37-80. PubMed ID: 20535881
[TBL] [Abstract][Full Text] [Related]
34. US concedes on cheaper drug production in Brazil.
Gottlieb S
BMJ; 2001 Jul; 323(7303):12. PubMed ID: 11440934
[No Abstract] [Full Text] [Related]
35. Taking TRIPS to India--Novartis, patent law, and access to medicines.
Mueller JM
N Engl J Med; 2007 Feb; 356(6):541-3. PubMed ID: 17287473
[No Abstract] [Full Text] [Related]
36. Drug companies sue South African government over generics.
Sidley P
BMJ; 2001 Feb; 322(7284):447. PubMed ID: 11222409
[No Abstract] [Full Text] [Related]
37. Pharmaceutical companies abandon case against South Africa: victory for people with HIV/AIDS.
Kleinsmidt A
Can HIV AIDS Policy Law Rev; 2001; 6(1-2):75-7. PubMed ID: 11837037
[TBL] [Abstract][Full Text] [Related]
38. AIDS and property rights in Africa.
Trotter G
Health Care Ethics USA; 2001; 9(2):E2. PubMed ID: 16184688
[No Abstract] [Full Text] [Related]
39. India: New patent law may restrict access to HIV/AIDS treatments.
Cruess G
HIV AIDS Policy Law Rev; 2005 Aug; 10(2):28-30. PubMed ID: 16365971
[TBL] [Abstract][Full Text] [Related]
40. March 5: "Global Day of Action against Drug Company Profiteering," as pharmaceutical companies sue South Africa to block low-cost medicines.
James JS
AIDS Treat News; 2001 Jan; (359):5-6. PubMed ID: 12173562
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
